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Fcc receptor (FccR)–mediated phagocytosis of IgG-coated particles is regulated by 39-phosphoinositides (39PIs) and
several classes of small GTPases, including ARF6 from the ADP Ribosylation Factor subfamily. The insensitivity of
phagocytosis to brefeldin A (BFA), an inhibitor of certain ARF guanine nucleotide exchange factors (GEFs), previously
indicated that ARF1 did not participate in phagocytosis. In this study, we show that ARF1 was activated during FccR-
mediated phagocytosis and that blocking normal ARF1 cycling inhibited phagosome closure. We examined the
distributions and activation patterns of ARF6 and ARF1 during FccR-mediated phagocytosis using fluorescence
resonance energy transfer (FRET) stoichiometric microscopy of macrophages expressing CFP- or YFP-chimeras of ARF1,
ARF6, and a GTP-ARF-binding protein domain. Both GTPases were activated by BFA-insensitive factors at sites of
phagocytosis. ARF6 activation was restricted to the leading edge of the phagocytic cup, while ARF1 activation was
delayed and delocalized over the phagosome. Phagocytic cups formed after inhibition of PI 3-kinase (PI-3K) contained
persistently activated ARF6 and minimally activated ARF1. This indicates that a PI-3K-dependent signal transition
defines the sequence of ARF GTPase activation during phagocytosis and that ARF6 and ARF1 coordinate different
functions at the forming phagosome.
Citation: Beemiller P, Hoppe AD, Swanson JA (2006) A phosphatidylinositol-3-kinase-dependent signal transition regulates ARF1 and ARF6 during Fcc receptor-mediated
phagocytosis. PLoS Biol 4(6): e162. DOI: 10.1371/journal.pbio.0040162
Introduction
Fcc receptor (FccR)-mediated phagocytosis by professional
phagocytes requires the extension of a tightly apposed, actin-
and membrane-rich pseudopod over the target particle. In
spite of this commitment of plasma membrane, macrophages
are able to engulf many particles without a concomitant loss
in surface area [1]. The observation that inhibitors of type I
phosphatidylinositol-3-kinase (PI-3K) prevent phagosome
closure, but do not completely abolish actin polymerization
and pseudopod extension, led to the suggestion that exocytic
membrane insertion at sites of phagocytosis may be required
for the complete extension of the phagosomal pseudopod [2].
The discovery that ADP ribosylation factor 6 (ARF6), a known
regulator of plasma membrane trafﬁcking, is required for
FccR-mediated phagocytosis, has underscored the link
between phagocytosis and membrane delivery [3,4].
Like all ARF GTP hydrolases (GTPases), ARF6 can regulate
membrane trafﬁcking events. In the context of phagocytosis,
ARF6 is thought to mediate the focal exocytosis of vesicles
that can fuse with the nascent phagosome [4]. ARF6 may also
contribute to phagocytosis through its ability to activate
lipid-modifying enzymes. GTP-bound ARF6 can activate
phosphatidylinositol 4-phosphate 5-kinase a (PI4P-5Ka) dur-
ing rufﬂing [5]. The product of PI4P-5Ka, phosphatidylino-
sitol-4,5-bisphosphate [PI(4,5)P2], can facilitate actin
polymerization through recruitment of WASP/N-WASP pro-
teins [6]. Since PI(4,5)P2 is the substrate for type I PI-3K,
ARF6 activation at the phagosome could contribute to the
ampliﬁcation of PI-3K signaling. ARF6 also activates phos-
pholipase D (PLD) [7]. Activation of PLD is known to mediate
a number of processes at the plasma membrane, including
rufﬂing [8] and cell motility [9], in addition to FccR-mediated
phagocytosis [10,11].
In contrast to ARF6, a role for ARF1 in phagocytosis has
been discounted. ARF1 regulates a variety of intracellular
trafﬁcking compartments including the recently identiﬁed
Golgi-localized, c-ear-containing, ARF-binding protein
(GGA) coats implicated in trans-Golgi network-endosome
trafﬁc [12]. The modular GGA-family proteins bind activated
ARF GTPases through their GGA and TOM (GAT) domains
[13]. However, in addition to its roles in Golgi trafﬁcking,
ARF1 can also serve as an effector of receptor-stimulated
processes: ARF1 regulates the endocytosis of the l-opioid
receptor in a PLD-dependent manner [14], co-activates PLD
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PLoS BIOLOGYin response to fMLP receptor ligation in neutrophils [15], and
mediates the recruitment of paxillin to focal adhesions [16].
The function of ARF1 at the Golgi complex is dependent
on Golgi-localized guanine nucleotide exchange factors
(GEFs) that catalyze GDP release and incorporation of
guanosine 59-triphosphate (GTP) into the ARF structure.
The binding of GTP stabilizes the interaction of ARF with
membranes, allowing it to recruit effectors to sites of vesicle
biogenesis [17,18]. The Golgi-associated GEFs generally are
inhibited by the fungal metabolite brefeldin A (BFA) [19,20],
distinguishing them from the BFA-insensitive cytohesin/
ARNO and EFA families of GEFs [21]. Previous work showed
that these BFA-resistant GEFs can regulate the activation of
ARF6 [22,23]. As ARF1 is typically thought to be regulated by
the BFA-sensitive GEFs, the observation that phagocytosis
proceeds in the presence of BFA suggested that ARF1 does
not contribute to phagocytosis [3]. However, the assignment
of GEFs to the regulation of different classes of ARF GTPases
is complicated by the observation that, at least in vitro,
cytohesin/ARNO family GEFs can catalyze nucleotide ex-
change on both ARF1 and ARF6 [22].
Immunoﬂuorescence and biochemical methods have con-
tributed greatly to our understanding of ARF GTPase
functions in the cell. However, previous methods have not
afforded a system for the in vivo observation of ARF
activation dynamics. As a result, the precise location of ARF
activation in the cell must be inferred from studies that rely
on the localization of GTP-binding or GTP-hydrolysis mutant
ARF proteins; these molecules may or may not accurately
reﬂect the localization of endogenous GDP- or GTP-bound
ARF proteins. Alternatively, biochemical methods have been
developed to measure ARF activation but are unable to
resolve where activation and deactivation occur in the cell. A
complete understanding of the role of ARF family members
in phagocytosis will require detailed analysis of the spatial
and temporal proﬁle of their activation during phagosome
formation. Of particular interest is the sequence of activation
of the various GTPases that coordinate the morphological
changes required for phagocytosis.
In this study, we have used ﬂuorescence microscopy to
measure the localization and activation of ARF6 and ARF1
GTPases during phagocytosis. We show that constitutively
active ARF1(Q71L) and the dominant-negative, GTP-binding-
deﬁcient ARF1(T31N) mutants partially inhibited phagocy-
tosis when expressed in macrophages as cyan ﬂuorescent
protein (CFP) chimeras. Macrophages expressing the mutant
ARF chimeras were able to initiate phagocytosis and began to
extend pseudopods over opsonized target particles. However,
the phagocytic cups in these macrophages frequently failed to
close, a result similar to the inhibition of phagocytosis
produced by the PI-3K inhibitor LY294002. Ratiometric
ﬂuorescence time-lapse microscopy indicated both ARF6-
YFP and ARF1-YFP chimeras localized to sites of FccR-
mediated phagocytosis. To quantify the activation of these
ARF molecules in vivo, we used a portion of the GGA1 GAT
domain, the a-helical N-GAT, to develop an assay based on
ﬂuorescence resonance energy transfer (FRET) stoichiometry
[24]. Using this FRET microscopy method, we observed that
both ARF6 and ARF1 were activated during the extension of
phagosomal pseudopods. Activation of ARF6 was concen-
trated at the tip of extending pseudopods, while ARF1 was
active throughout the forming phagosome. ARF6 activation
was independent of PI-3K activity, but deactivation of ARF6
required PI-3K function. In contrast, ARF1 activation at the
phagosome was blocked by PI-3K inhibition. Furthermore, we
found that the phagosome-localized activation of ARF1 was
unaffected by BFA, indicating ARF1 may be regulated by
cytohesin/ARNO family GEFs in response to FccR ligation.
The distinct responses of ARF6 and ARF1 activation to PI-3K
inhibition suggests that these ARF GTPases regulate distinct
functions during FccR-mediated phagocytosis.
Results
FRET-Based Measurement of ARF GTPase Activation
To localize ARF activation inside live cells, we developed a
FRET microscopic method based on the interaction between
GTP-bound ARFs and GGA-family protein GAT domains.
The binding of GAT domains to activated ARFs has been used
previously for biochemical measurements of ARF6 activation
[4,9]. To create a marker that distributes in the cell solely in
an ARF-GTP-dependent manner, we created a fusion of
yellow ﬂuorescent protein (YFP) to 45 amino acids from the
N-terminus of the GGA1 GAT domain (NGAT). This frag-
ment of the GAT domain incorporates all the amino acid
residues known to contribute to the binding of ARF-GTP
[25,26,27] but lacks the C-terminal segment that interacts
with the Rab5 GTPase activating protein (GAP) Rabaptin-5
[28]. The afﬁnity of this NGAT domain for ARF1-GTP was
reported to be comparable to the afﬁnity of the full-length
GGA1 GAT domain [29]. Despite its ability to bind to ARF-
GTP, expression of YFP-NGAT was not toxic to macrophages,
nor did it appear to inhibit phagocytosis (see below). In
contrast, we were not able to express at high levels in
macrophages a YFP-NGAT construct derived from the
human GGA3 cDNA; this construct inhibited phagocytosis
even at low expression levels. We attribute these different
results for the two chimeras to different afﬁnities for ARF-
GTP. The apparently lower afﬁnity of the GGA1-derived YFP-
NGAT allowed it to act as a reporter of ARF activation
without inhibiting the RAW264.7 cells’ phagocytic functions.
When co-expressed in cells, the binding of YFP-NGAT to
GTP-bound ARF-CFP chimeras could be detected using FRET
microscopy. Following collection of IA,I D, and IF images,
image processing using FRET stoichiometry generated two
images that reﬂect the GTP-dependent interaction of ARF-
CFP and YFP-NGAT chimeras [30]: EA, which is proportional
to the fraction of YFP acceptors in complex with CFP donors,
and ED, which is proportional to the fraction of CFP donors
bound to YFP acceptors. Increases and decreases in the EA
and ED images reﬂect changes in the amount of ARF-CFP
complexed with YFP-NGAT. Additionally, from the compo-
nent ﬂuorescence images, FRET stoichiometry determines
RM: the molar ratio of all YFP acceptors (free and complexed)
to all CFP donor molecules.
To evaluate the ability of this method to detect ARF-GTP,
RAW264.7 macrophage-like cells co-expressing ARF1-CFP
and YFP-NGAT were used to visualize activated ARF1 at the
Golgi apparatus and to measure ARF1 deactivation in
response to BFA. On the molecular level, BFA binds an
ARF–GDP–GEF intermediate complex preventing release of
the GDP nucleotide [31]. At the organellar level, this results in
the collapse of the Golgi stacks [32].
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ARF1 and ARF6 during PhagocytosisFigure 1. Measurement of ARF Activation Using FRET Stoichiometry
(A) Time points (in minutes) are relative to the addition of 5 lm BFA. ARF1-CFP and YFP-NGAT were enriched at the Golgi complex in transfected
RAW264.7 macrophages. BFA rapidly disintegrated the Golgi network (shrinking region outlined in red in the ARF1-CFP panels), and the fluorescent
markers redistributed to the cytosol. Color bars to the right of the ED and RM panels indicate the magnitude of ED expressed as a percent, and the molar
ratio of YFP-NGAT/ARF1-CFP, respectively. The values to the right of the color bar indicate the values of the pixel colors at the ends of the scale. For
each image series and video presented in this work, all images within a single time series are identically scaled and directly comparable. Note that in the
region of the Golgi apparatus, ARF1-CFP was present at an ;2.5-fold molar excess relative to YFP-NGAT. YFP-NGAT localization to the Golgi apparatus
was mediated by ARF1-GTP binding as indicated by the high ED values at the Golgi. The FRET-based detection of ARF1-activation rapidly decreased
after the addition of BFA; nearly all ARF1 activation was blocked within ;5 minutes of the addition of BFA. The scale bar located in the upper right of
the CFP time series is 6 lm.
(B) The decrease in ED signals at the Golgi apparatus corresponding to loss of active ARF1 was quantified. An inclusive threshold was used to generate
regions (as shown in the ARF1-CFP panels above) and to mask the ED image to measure the Golgi-associated activation of ARF1 after BFA addition.
Following the addition of BFA (dotted line), ARF1-GTP levels at the Golgi immediately began to decrease; n ¼ 6 cells.
Error bars represent 6 the standard error of the mean (SEM).
(C) FRET values expressed as the average of the percent EA and ED signals were measured in macrophages expressing the indicated FRET partners. The
dominant-negative ARF-CFP chimeras produced low, but detectable, FRET signals when co-expressed with YFP-NGAT. Conversely, co-expression of the
constitutively active ARF1(Q71L)-CFP or ARF6(Q67L)-CFP chimeras with YFP-NGAT produced elevated FRET signals compared with wild-type ARF-CFP
chimeras. ARF1(Q71L)-CFP and YFP-NGAT generated slightly elevated FRET signals at the Golgi apparatus. The bar plots to the right of the black line are
FRET signals measured when the listed ARF-CFP chimera was co-expressed with YFP-NGAT(A193T, N194Y), an NGAT molecule with reduced ARF-GTP
binding affinity. Neither the wild-type nor constitutively activated ARF-CFP chimeras generated high FRET signals when co-expressed with YFP-
NGAT(A193T, N194Y). Measurements for each FRET pair are the average from at least 25 cells, and error bars represent plus/minus the standard
deviation.
DOI: 10.1371/journal.pbio.0040162.g001
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ARF1 and ARF6 during PhagocytosisPrior to the addition of BFA, ARF1-CFP and YFP-NGAT
colocalized to the juxtanuclear region but were also present
throughout the cytoplasm (Figure 1A). ARF1-CFP accumu-
lation resulted in a molar excess of ARF1-CFP donors to YFP-
NGAT acceptors at the Golgi complex (Figure 1A, RM panels).
This site of ARF1-CFP and YFP-NGAT colocalization
corresponded to the region of high ED indicating binding
of YFP-NGAT to activated ARF1-CFP (Figure 1A, time 0 ED
image). Following the addition of 5 lM BFA to macrophages,
both ARF1-CFP and YFP-NGAT redistributed to the cyto-
plasm (Figure 1A). YFP-NGAT completely dispersed within
;5 min of the addition of BFA. ARF1-CFP was also rapidly
released from the Golgi complex but remained slightly
enriched in the juxtanuclear region for ;15 min after BFA
addition. Similarly, both the ED (Figure 1A and 1B) and EA
(unpublished data) signals at the Golgi apparatus rapidly
decreased after the delivery of BFA. With activation of ARF1
arrested by BFA, stimulation of GTP hydrolysis by endoge-
nous GAPs led to the rapid deactivation of all ARF1-CFP at
the Golgi complex within ;7 min. The kinetics observed for
BFA-induced ARF1-CFP and YFP-NGAT redistribution and
ARF1 deactivation were consistent with a previous study of
the effects of BFA on the localization of ARF1-CFP and YFP-
GAT chimeras [26].
When YFP-NGAT was co-expressed in RAW264.7 cells with
ARF1(T31N)-CFP or ARF6(T27N)-CFP, mutations known to
reduce the afﬁnity of the ARF GTPases for GTP [33,34], cells
exhibited reduced FRET signals (Figure 1C). Similarly, much
lower FRET signals were measured from cells expressing wild-
type ARF-CFP chimeras with YFP-NGAT(A193T, N194Y).
This mutant NGAT construct is expected to have signiﬁcantly
reduced afﬁnity for ARF-GTP based on previous studies of
the ARF-GAT domain interaction [25–27]. In contrast, the
constitutively active mutants ARF1(Q71L)-CFP and
ARF6(Q67L)-CFP both produced elevated FRET signals when
co-expressed with YFP-NGAT in macrophages (Figure 1C);
however, increased FRET signals were not seen when the GTP
hydrolysis-deﬁcient ARF molecules were co-expressed with
the YFP-NGAT(A193T, N194Y) molecule. The average FRET
values measured from cells expressing the constitutively
active or constitutively inactive ARF-CFP chimeras were
signiﬁcantly different from the corresponding wild-type CFP
chimeras (Mann-Whitney U test, p , 0.001). Likewise, the
FRET values obtained from cells expressing the mutant YFP-
NGAT chimera with wild-type or constitutively active ARF-
CFP were signiﬁcantly different from the wild-type YFP-
NGAT controls (p , 0.001). The average EA,E D,E AVG, and RM
values of the samples used to produce Figure 1C can be found
in Table S1. The ARF-CFP chimeras never indicated FRET
when co-expressed with free YFP (unpublished data). These
results indicate that the FRET signals measured by FRET
stoichiometry are dependent on the binding of activated
ARF-CFP chimeras to the YFP-NGAT molecule, and that
FRET stoichiometry is capable of measuring ARF activation
dynamics in living cells.
Localization of ARF6, ARF1, and NGAT during FccR-
Phagocytosis
Time-lapse ratiometric microscopy of RAW264.7 cells
engaged in phagocytosis of IgG-opsonized erythrocytes, and
expressing CFP and ARF6-YFP or ARF1-YFP, was used to
localize the GTP-binding proteins to sites of phagocytosis. RM
imagescalculated from cellsexpressing YFPchimeras andCFP
represent the molar ratio of YFP chimera relative to soluble
CFP at each pixel in the image. As such, RM images generated
from cells co-expressing YFP chimeras with CFP measure the
speciﬁc recruitment of YFP chimeras to sites in the cell
independentofpath-lengthcontributionstoimageintensities.
Based on the average length of time required to complete
phagocytosis, expression of ARF6-YFP did not inhibit
phagocytosis. During phagocytosis, ARF6-YFP was recruited
to the leading edges of extending pseudopods (Figure 2A).
The highest ARF6-YFP enrichment occurred in the front of
the advancing phagocytic cups, and ARF6-YFP was prom-
inently enriched in post-phagocytic rufﬂes after engulfment
of the opsonized erythrocytes. Following closure of the
phagosome at ;7–8 min after erythrocyte binding, ARF6-
YFP remained associated with the phagosome at moderate
levels relative to the surrounding cytoplasm (Figure 2A and
2B). Analysis of multiple phagosomes showed that ARF6-YFP
localization to the phagosome increased rapidly during the
extension of phagosome pseudopods, peaked within ;2.5
min of the initiation of phagocytosis, then gradually
diminished (Figure 2B).
Unlike ARF6, ARF1-YFP recruitment did not consistently
associate with a particular subregion of the phagosome
(Figure 2C). Maximum recruitment of ARF1-YFP to the
phagosome occurred later than the peak in ARF6-YFP
localization (Figure 2B and 2D). Based on the aggregate
analysis of independent phagosomes, recruitment of ARF1-
YFP appeared biphasic: ARF1-YFP was transiently recruited
upon the initiation of pseudopod extension but was recruited
to greater extent as phagosomes neared closure. ARF1
recruitment to the phagosome plateaued shortly after sealing
of the phagosome (;10 min) and remained elevated over the
course of observation (Figure 2D).
We next attempted to use the YFP-NGAT fusion protein to
measure the distribution of endogenous activated ARF
proteins at the phagosome. The YFP-NGAT chimera was
distinctly enriched at juxtanuclear sites indicating binding to
endogenous, activated ARFs in the Golgi network (Figure 1B).
However, during FccR-mediated phagocytosis, no signiﬁcant
recruitment of the YFP-NGAT chimera to phagosomes was
observed (Figure 2E and 2F). Analysis of these phagosomes
suggested that either limited or no activation of endogenous
ARF proteins occurred during phagocytosis, or the afﬁnity of
the YFP-NGAT chimera for activated ARF proteins did not
allow it to compete effectively with endogenous ARF-GTP-
binding proteins. Pretreatment of macrophages with BFA
prior to microscopic observation redistributed the YFP-
NGAT evenly throughout the cell; however, YFP-NGAT still
did not appear to localize to sites of phagocytosis in these
cells (Figure 2F). The fact that YFP-NGAT was not recruited
to phagosomes, combined with the observation that YFP-
NGAT did accumulate at the Golgi complex, indicates the
total level of ARF-GTP at the phagosome was much lower
than the amount of activated ARF in the Golgi compartment.
ARF6 and ARF1 Activation at Sites of Phagocytosis
To measure the GTP-binding state of ARF6 and ARF1 at
phagosomes, ARF6-CFP or ARF1-CFP chimeras were co-
expressed with YFP-NGAT chimeras in RAW264.7 cells and
observed during FccR-mediated phagocytosis. In macro-
phages co-transfected with ARF6-CFP and YFP-NGAT,
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ARF1 and ARF6 during Phagocytosisactivated ARF6-CFP was observed in rufﬂes (Video S1),
consistent with previous work that demonstrated ARF6 and
ARNO3 translocate to sites of rufﬂing [23]. Although rufﬂes
and phagosomes typically displayed comparable ED values,
ARF6 accumulated to a greater extent at phagosomes than in
rufﬂes (Video S1). This indicates that while the fraction of
ARF6 bound to GTP was approximately equal in rufﬂes and
phagosomes, the total amount of ARF6 activated in response
to FccR-ligation was higher.
In our analysis of 11 phagosomes, ARF6 was activated
during all phagocytic events, although the magnitude of the
activation varied signiﬁcantly between phagosomes. FRET
microscopy indicated ARF6 activation immediately upon
binding of opsonized particles to the surfaces of macrophages
(Figure 3A). During extension of the phagocytic cup,
activated ARF6-CFP was concentrated at the advancing edge
of the pseudopod with lower ED values over the base of the
phagosome (Figure 3A and Video S1). Based on particle-
tracking analysis of multiple phagosomes, the maximum
activation of ARF6-CFP occurred within the ﬁrst two minutes
of phagocytosis and most of the ARF6-CFP on the phag-
osomal membrane was deactivated by the time of phagosome
closure (;7–8 min) (Figure 3A and 3B and Video S1). It
should be noted that to make quantitative comparisons of
independent phagocytic events, the particle-tracking analysis
discards much of the spatial resolution provided by the
microscope. Comparing the averaged tracking analysis results
to the time series of ARF6 activation (compare Figure 3B and
3C) showed that the immediate decrease in ED signal
following erythrocyte binding seen in the tracking results
was not reﬂected in the time series of ED images. This is the
result of the advance of an increasing portion of the
pseudopod into the measurement region; as the measure-
ment region encompasses a larger area of the macrophage
Figure 2. Ratiometric Microscopy of Arf6-YFP, ARF1-YFP, and YFP-NGAT at the Phagosome
Ratiometric fluorescence microscopy of macrophages expressing ARF1-YFP, ARF6-YFP, or YFP-NGAT chimeras with soluble CFP during phagocytosis.
(A, C, and E) Phase contrast (PC) and ratiometric images of macrophages during the phagocytosis of IgG-opsonized erythrocytes. Scale bars are 3 lm.
Color bars indicate the molar ratio of YFP-chimera/CFP in the adjacent RM images.
(B, D, and F) Plots of the average recruitment index (Ri) for temporally aligned phagocytic events.
Error bars correspond to 6 SEM.
(A) ARF6-YFP rapidly accumulated at sites of phagocytosis; the region of high ARF6-YFP concentration advanced over the particle during pseudopod
extension.
(B) Analysis of multiple phagosomes indicated that the level of ARF6-YFP on the phagosome peaked during the first 2.5 min of engulfment. Following
this initial rise, localization to the phagosome gradually decreased but ARF6-YFP remained associated with the phagosome well after closure at 7–8 min;
n ¼ 10 phagosomes.
(C) ARF1-YFP localization to the phagosome was less pronounced than ARF6-YFP. ARF1-YFP generally accumulated over the entire phagosome and was
also slightly enriched in membrane ruffles formed following closure.
(D) Averaged particle-tracking results indicated ARF1-YFP association increased transiently during the first 2 min of phagosome formation, then
increased further after 5 min. ARF1-YFP levels at the phagosome plateaued shortly after closure and remained elevated over the course of observation;
n ¼ 11 phagosomes.
(E) The concentration of YFP-NGAT did not increase at sites of phagocytosis relative to the cytosol, indicating the level of activated ARF GTPases at the
phagosome was too low to detect using YFP-NGAT ratiometric imaging.
(F) Aggregate particle-tracking data never indicated recruitment of YFP-NGAT to phagosomes in the presence or absence of the ARF GEF inhibitor BFA.
The time course of phagosomes formed without BFA pretreatment is the average of seven phagosomes. The plot of phagosomes formed in the
presence of BFA was generated from ten phagocytic events.
DOI: 10.1371/journal.pbio.0040162.g002
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ARF1 and ARF6 during Phagocytosiscytoplasm, the FRET signal at the advancing tip is averaged
with the trailing region of low FRET. Similar patterns and
proﬁles were reported for Cdc42 activation [30].
In contrast to ARF6-CFP, ARF1-CFP activation generally
increased during pseudopod extension, but ARF1-CFP was
also mostly deactivated by the time of phagosome closure
(Figure 3C and 3D and Video S2). The timing of peak ARF1-
CFP activation varied from phagosome to phagosome with
peaks at 0 min (one phagocytic event), 0.5 min (two events), 1
min (one event), 1.5 min (one event), 2.5 min (three events),
3.5 min (one event), and 4 min (one event). The region of high
ED was not restricted to a subregion of the nascent
phagosome but rather was generally distributed over most
of the particle.
To identify the family of ARF GEFs that catalyzed the
activation of ARF1-CFP at sites of phagocytosis, macrophages
co-expressing ARF1-CFP and YFP-NGAT were pretreated
with BFA before microscopic observation. Prior to phagocy-
tosis, these cells exhibited uniform molar ratios of YFP-
NGAT/ARF1-CFP throughout their cytoplasm, and ED values
in these cells were ;0. Similar to phagocytic events that
occurred in the absence of BFA, upon particle binding ARF1-
CFP activation increased, peaking within 4 min of the start of
phagocytosis. Deactivation occurred as the phagosome closed
over the target (Figure 3D and Video S3). Based on the
tracking of multiple phagosomes, the magnitude and timing
of ARF1 activation and deactivation at sites of phagocytosis
were not affected by the presence of BFA (Figure 3D and
Video S3). ARF6 activation also was not affected by the
presence of BFA (unpublished data). The BFA-resistance of
phagosome-associated ARF1-CFP activation implicates a
member of the cytohesin/ARNO family of GEFs in the
function of ARF1 during phagocytosis.
When ARF6-CFP or ARF1-CFP were co-expressed with a
Figure 3. Measurement of ARF6-CFP and ARF1-CFP Activation at Phagosomes
FRET microscopic measurement of ARF6-CFP and ARF1-CFP activation during phagocytosis.
(A, C, and E) Phase contrast and ED images of phagocytic events from macrophages co-expressing ARF6-CFP and YFP-NGAT, ARF1-CFP and YFP-NGAT,
or ARF6-CFP and YFP-mutant NGAT. Scale bars in the upper right of the phase contrast series are 3 lm.
(B, D, and F) Plots of ED against phagosome progress for the corresponding pairs in (A), (C), and (E).
Error bars indicate 6 SEM.
(A) ARF6-CFP activation peaked shortly after particle binding. Activated molecules were concentrated at the leading edge of the phagosome with lower
levels of ARF6-GTP in the region trailing the advancing edge of the pseudopod.
(B) Based on compiled particle-tracking results, maximum ARF6-CFP activation occurred shortly after the initiation of phagocytosis, and most of the
ARF6-CFP was deactivated by the time of closure (;7–8 min after the initiation of phagocytosis); n ¼ 11 phagocytic events.
(C) The peak in ARF1-CFP activation was slightly delayed relative to ARF6-CFP, and ARF1-GTP was not restricted to a subregion of the phagosome.
ARF1-GTP levels began to decrease as the closure phase began. The persistent Golgi-associated FRET signal indicated ARF1-GTP levels at the Golgi did
not fluctuate during phagocytosis.
(D) Analysis of multiple phagosomes indicated ARF1-CFP was also almost entirely deactivated by the time of phagosome closure; n¼14. The presence
of BFA did not inhibit the activation of ARF1-CFP at sites of phagocytosis, suggesting ARF1 is activated by BFA-insensitive GEFs during phagocytosis.1 4
phagocytic events that occurred in the presence of 5 lM BFA were analyzed by particle-tracking analysis.
(E) ARF6-CFP produced very low ED values at sites of phagocytosis when co-expressed with YFP-NGAT(A193T, N194Y).
(F) Multiple phagosomes from macrophages co-expressing the binding-deficient YFP-NGAT(A193T, N194Y) with ARF6-CFP (blue) or ARF1-CFP (green)
never demonstrated significant FRET signals. ARF1 results are the average of 15 phagosomes; ARF6 results represent eight phagosomes.
DOI: 10.1371/journal.pbio.0040162.g003
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ARF1 and ARF6 during PhagocytosismutantYFP-NGAT(A193T,N194Y)designedtoblockbindingto
activated ARF proteins, macrophages demonstrated low FRET
signals of 0%–1% throughout their cytoplasm with no increase
observed at the phagosome (Figure 3E and 3F). The low ED
signalsinthesecontrolcellsindicatedthatFRETwasdependent
on the binding of YFP-NGAT to activated ARF GTPases.
ARF1 Activation and ARF6 Deactivation at Sites of
Phagocytosis Required PI-3K Activity
To determine whether the activation of ARF1 and ARF6 at
phagosomes was regulated by PI-3K, macrophages co-ex-
pressing YFP-NGAT with ARF1-CFP or ARF6-CFP were
exposed to LY294002 to inhibit PI-3K activity prior to
microscopic observation. Treatment with LY294002 inhibits
the production of phosphatidylinositol-3,4,5-trisphosphate
[PI(3,4,5)P3], blocking phagocytosis at a stage distal to
receptor ligation and phagocytic cup formation [35,36].
Despite the presence of LY294002, formation of the phag-
ocytic cup was accompanied by activation of ARF6-CFP
(Figure 4A and Video S4). Particle-tracking analysis indicated
ARF6-CFP was still activated immediately upon binding and
remained activated over the course of observation (Figure 4B).
Despite the activation of ARF6, macrophages were not able to
complete phagocytosis in the presence of PI-3K inhibitor.
This result suggests that ARF6 deactivation at the phagosome,
rather than activation, is coupled to PI-3K activity.
In contrast, ARF1-CFP activation at phagocytic cups did
not increase in the presence of PI-3K inhibitor (Figure 4C
and Video S5). Macrophages challenged with LY294002 still
demonstrated low levels of ARF1-GTP at phagocytic cups but
did not produce the transient increase in ARF1 activation
observed during phagocytosis in the absence of LY294002
(compare Figures 3D and 4D). Multiple phagosomes never
indicated an increase in ARF1-CFP activation at sites of
phagocytosis, although Golgi-associated ARF1-CFP activation
persisted in the presence of LY294002 (Figure 4C). Taken
together, these results indicate ARF1 activation at the
phagosome was dependent on a PI-3K-regulated activity,
and that LY294002 arrested phagocytosis at a point preceding
ARF6 deactivation.
ARF1 GTPase Mutants Block Phagocytosis after the
Initiation of Pseudopod Extension
To test the effects of the constitutively active and
dominant-negative ARF-CFP molecules on phagocytosis, we
measured phagocytic efﬁciencies for cells expressing CFP,
wild-type ARF-CFP, or cycling mutant ARF-CFP chimeras.
Expression of ARF1-CFP reduced the binding index of
macrophages by 40% compared with macrophages express-
ing CFP, and expression of the cycling mutant ARF1-CFP
chimeras reduced binding indexes by ;40%–50% (Figure
5A). Despite the reduction in the number of erythrocytes
bound, macrophages expressing ARF1-CFP were able to
internalize bound, opsonized erythrocytes with the same
efﬁciency as macrophages expressing CFP. However, expres-
sion of ARF1(T31N)-CFP or ARF1(Q71L)-CFP reduced the
phagocytic efﬁciency of macrophages by approximately 2-
fold compared with cells expressing CFP (Figure 5B).
Figure 4. Activation of ARF6 and ARF1 during Phagocytosis in Macrophages Pretreated with LY294002
Macrophages co-expressing ARF6-CFP or ARF1-CFP with YFP-NGAT were treated with LY294002 for 30 min to inhibit PI-3K.
(A) Phase contrast and ED images from an RAW264.7 macrophage expressing ARF6-CFP and YFP-NGAT. Binding of the IgG-opsonized erythrocyte led to
activation of ARF6-CFP, but the phagosome never closed, and ARF6-CFP was not deactivated.
(B) The particle-tracking analysis for ten phagosomes from cells co-expressing ARF6-CFP and YFP-NGAT indicated that the magnitude of ARF6 activation
in response to FccR ligation was not reduced, but ARF6 deactivation could not proceed in the presence of PI-3K inhibitor.
(C) Phase contrast and ED images from a macrophage expressing ARF1-CFP and YFP-NGAT did not demonstrate a phagosome-localized activation of
ARF1 in the presence of LY294002. However, ARF1-CFP activation at the Golgi apparatus appeared to be unaffected (crescent-shaped region of high ED
near the nucleus).
(D) Measurement of ARF1 activation in LY294002 by particle-tracking analysis of nine phagosomes showed that a consistent but low level of ARF1 was
bound to GTP at phagocytic cups; these macrophages did not display the transient, localized activation of ARF1 seen in control cells not treated with
LY294002.
Gray lines in (B) and (D) are the activation profiles in the absence of LY294002 for ARF6 and ARF1, respectively, taken from Figure 3B and 3D.
Error bars represent 6 SEM.
Scale bars in (A) and (C) are 3 lm.
DOI: 10.1371/journal.pbio.0040162.g004
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ARF1 and ARF6 during PhagocytosisFigure 5. Effect of ARF1 and ARF6 Cycling Mutants on the Phagocytic Efficiciency of Macrophages and Imaging of ARF1(T31N)- and ARF1(Q71L)-
Arrested Phagosomes
(A) The effects of expression of the ARF-CFP chimeras on the binding of opsonized target particles. The ARF1-CFP chimeras generally reduced the
binding index of macrophages, while the ARF6-CFP chimeras did not affect target particle binding.
(B) Phagocytic indexes were measured for macrophages expressing CFP fusions of ARF1, ARF1(T31N), ARF1(Q71L), ARF6, ARF6(T27N), or ARF6(Q67L).
The number of internalized and bound, uninternalized erythrocytes were counted for macrophages expressing the various constructs. Although ARF1-
CFP did not reduce phagocytosis, expression of ARF1(T31N)-CFP or ARF1(Q71L)-CFP led to a reduction in phagocytic efficiency. Similarly, ARF6-CFP, in
its wild-type form, produced a small inhibition of phagocytosis, but the constitutively activated and dominant-negative forms of ARF6-CFP impaired
phagocytosis to a much greater degree. For all constructs except ARF6(Q67L)-CFP, results are the average of at least two experiments in which three
coverslips were assayed. At least 25 macrophages were counted per coverslip. The ARF6(Q67L)-CFP results are from 31 macrophages counted on six
coverslips.
The error bars in (A) and (B) represent 6 SEM.
(C and D) Time-lapse fluorescence microscopy from macrophages expressing YFP-NGAT and ARF1(T31N)-CFP or ARF1(Q71L)-CFP. Note that the last
image in the series was taken 25 min after the initiation of phagocytosis. Control RAW264.7 macrophages typically required 6–8 min to complete
phagocytosis from the onset of pseudopod extension. The scale bars in the far-right phase contrast panels are 3 lm.
(C) In macrophages expressing ARF1(T31N)-CFP, phagocytic cups formed, but the macrophages failed to close the phagosome.
(D) Expression of ARF1(Q71L)-CFP also prevented phagosome closure. The phagocytic cup is visible in the fluorescence image.
DOI: 10.1371/journal.pbio.0040162.g005
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ARF1 and ARF6 during PhagocytosisStudent’s t-tests indicated that the phagocytic efﬁciencies of
the macrophages expressing the ARF1-CFP mutants were
signiﬁcantly different from the macrophages expressing CFP
(p   0.01). Similarly, we found that while wild-type ARF6-CFP
produced a 20% decrease in phagocytic efﬁciency when
compared with macrophages expressing CFP, the cycling
mutants ARF6(T27N)-CFP and ARF6(Q67L)-CFP sharply
reduced the phagocytic efﬁciency of the RAW264.7 macro-
phages by at least 70% (Figure 5B). None of the ARF6
chimeras had a large effect on the binding indexes of
macrophages (Figure 5A). These results demonstrate that
the closure of FccR-mediated phagosomes is dependent on
the normal cycling of both the ARF1 and ARF6 GTPases.
To determine the stage at which mutant ARF1 arrested
phagocytosis, time-lapseﬂuorescence microscopy movies were
acquiredusingRAW264.7macrophagesexpressingYFP-NGAT
and ARF1(T31N)-CFP or ARF1(Q71L)-CFP. In macrophages
expressing ARF1(T31N)-CFP and YFP-NGAT, neither marker
accumulatedinthejuxtanuclearregion.Incontrast,expression
of ARF1(Q71L)-CFP did not inhibit the localization of YFP-
NGAT to the juxtanuclear Golgi region. However, the Golgi
compartment did frequently appear more fragmented in
macrophages expressing the constitutively active ARF1 chi-
mera.MacrophagesexpressingeitherofthesemutantARF-CFP
chimeras were able to initiate phagocytosis. However, phag-
ocytic cups formed in macrophages expressing ARF1(T31N)-
CFP or ARF1(Q71L)-CFP did not progress past pseudopod
extension (Figure 5C and 5D). The macrophages expressing
ARF1(T31N)-CFP and YFP-NGAT never exhibited FRET.
Macrophages expressing ARF1(Q71L)-CFP and YFP-NGAT
diddisplayFRET;however,theFRETsignalsobservedwerenot
dynamic (Figure 5D). The phagocytic cups formed in these
macrophages resemble the cups formed when PI-3K activity
wasinhibitedbypretreatmentof macrophageswithLY294002.
Discussion
FRET microscopy revealed that PI-3K activity establishes a
molecular switch that controls the activation dynamics of
ARF GTPases during FccR-mediated phagocytosis. This signal
transition comprises a temporal boundary identiﬁed by the
deactivation of ARF6 and the activation of ARF1. This PI-3K-
dependent regulatory mechanism deﬁnes a sequence of
signaling events during phagocytosis. While this progression
occurs smoothly as the phagocyte engulfs the particle, the
signal transition initiated by 39PIs distinguishes early and late
phagosomal activites regulated by different GTPases from the
ARF, and perhaps Rho, family.
It was previously demonstrated that PI-3K is recruited to
phagosomes, and that PI(3,4,5)P3 accumulates at phagosomes,
reaching a plateau shortly before closure, then is cleared
from phagosome [37]. These observations can be aligned with
the signal transition model presented here. As phagocytosis
commences, ARF6 is activated independently of PI(3,4,5)P3
production. However, as PI-3K products accumulate in the
phagocytic membrane, GAP activities are recruited to
deactivate ARF6, while GEFs simultaneously translocate to
the phagosome to activate ARF1. As PI(3,4,5)P3 is cleared
from the closing phagosome, ARF1 GEF activity also
decreases, and all ARF GTPases are deactivated.
ARF6 was rapidly activated upon FccR ligation and
primarily active during pseudopod extension. ARF6 activa-
tion was focused at the advancing edge of pseudopods, where
it may regulate the exocytosis of membrane to complete
particle engulfment [2,4]. The decreasing ED values seen at
phagocytic cups during closure likely correspond to deacti-
vation of ARF6-GTP. Alternatively, the loss of FRET signal
may be attributable to displacement of the YFP-NGAT
reporter by endogenous effectors. The activation proﬁle of
ARF6 was essentially identical to the proﬁle for Cdc42, which
preceded maximal Rac1/Rac2 activation [30]. The activation
of ARF6 and Cdc42 in a conﬁned band at the leading edge of
pseudopods is manifested in the particle-tracking results as
initially high FRET values that begin to trend downward
immediately due to the advance of the macrophage cytoplasm
into the phagosome-measurement region, which displays low
levels of activated ARF6 (see Figure 3B). This indicates that
Cdc42 and ARF6 regulate processes required for the
extension of pseudopods immediately after binding of
opsonized targets. The activation proﬁles for ARF6, Cdc42,
and Rac estimated using FRET microscopy and particle-
tracking analysis differ from the proﬁles measured biochemi-
cally [4]; pull-down assays indicated that Rac activation
precedes Cdc42 and ARF6 activation. This difference may
be explained by the superior temporal resolution provided by
the FRET microscopic approach.
ARF6 activation appeared to be independent of PI-3K
activity as LY294002 did not reduce ARF6-GTP levels in the
phagocytic cup (Figure 4A and 4B and Video S4). Rather, PI-
3K function was required for the deactivation of ARF6,
suggesting that PI-3K regulates closure activities rather than
pseudopod extension. The activation of ARF6 was surprising
given previous studies that demonstrated GEFs from the
ARNO/cytohesin family translocate to the plasma membrane
in a PI-3K-dependent fashion [38,39]. Based on our results, we
hypothesize that the redistribution of these GEFs in a PI-3K-
dependent manner correlates with ARF1, not ARF6, activa-
tion, and that ARF1 regulates phagosome closure. Accord-
ingly, ARF1 activation at phagosomes was reduced by
LY294002, while activation of ARF1 in the Golgi compart-
ment was unaffected by the presence of the PI-3K inhibitor
(Figure 4C and 4D and Video S5). Also, the peak activation of
ARF1 occurred after maximum ARF6 activation and was not
conﬁned to the leading edge of pseudopods.
The inability of BFA to inhibit phagosome formation led to
the hypothesis that ARF1 activation is not required for
phagocytosis [3]. However, the possibility of ARF1 activation
by BFA-insensitive GEFs during phagocytosis was not
excluded. We observed that BFA did not alter the timing or
magnitude of ARF1 activation during phagocytosis, suggest-
ing that ARF1 is an in vivo substrate of ARNO/cytohesin-
family GEFs. The activation of ARF1 during phagocytosis did
not appear to be gratuitous as we observed that ARF1(T31N)
and ARF1(Q71L) blocked phagocytosis after the initiation of
pseudopod formation. As ARF6 was activated primarily
during the early time points of pseudopod extension, it is
unlikely that the blockade induced by the ARF1 cycling
mutants was due to a nonspeciﬁc effect on ARF6 activation.
Given the prominent role of ARF1 in the trafﬁcking of
proteins through the Golgi network, it is possible that the
effects of the ARF1 mutants on phagocytosis are due to a
nonspeciﬁc effect on receptor trafﬁcking. However, given
that wild-type ARF1-CFP also reduced the binding indexes of
macrophages without impacting their ability to phagocytose
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ARF1 and ARF6 during Phagocytosisbound targets, it is possible the reduced binding indexes are
simply a reﬂection of the different morphology of cells
expressing ARF1-CFP chimeras. Alternatively, the reduction
of binding indexes seen in cells expressing the cycling mutant
ARF1 chimeras may reﬂect a role for ARF1 in the trafﬁcking
of Fcc receptors.
The fact that their activation dynamics are independently
regulated during phagocytosis suggests that these ARF
GTPases coordinate distinct activities at the phagosome.
ARF6 appears primarily to control early events in phagocy-
tosis that occur upstream of PI-3K signaling [4]. ARF6 may
coordinate these processes in conjunction with Cdc42 and
Rac1 [30], including the membrane delivery and actin
polymerization required to envelop target particles. ARF1
on the phagosome is activated downstream of PI-3K
ampliﬁcation of receptor signaling. ARF1 may be involved
in the oxidative burst coupled to FccR-mediated phagocytosis
[40]. ARF1 was previously implicated in the BFA-resistant,
fMLP-stimulated activation of PLD, a process that leads to
increased production of reactive oxygen intermediate in
neutrophils [15]. ARF1 might also stimulate the oxidative
burst through its ability to bind Arfaptin. Arfaptin has been
shown to bind to Rac proteins in both their GDP- and GTP-
bound states but speciﬁcally binds to activated ARF GTPases
[41]. Accordingly, Arfaptin might sequester Rac in the
absence of ARF-GTP. Generation of ARF-GTP would free
Rac for incorporation into functional phagocyte oxidase
complexes. In this model, ARF1 would co-activate the
oxidative burst with Rac2, a GTPase that is primarily active
during the closure phase of phagocytosis [30]. Given the
restriction of ARF6 activation to the leading edge of the
phagosome and the proﬁle of Rac activation described
previously [30], ARF1 would appear to be a better candidate
for this function.
A crucial question is how the activity of the BFA-resistant
GEFs could regulate ARF6 and ARF1 in distinct patterns.
Independent regulation of ARF6 and ARF1 may depend on
the preference of the GEFs’ exchange domains for different
ARFs. EFA6 can efﬁciently catalyze nucleotide exchange on
ARF6 but not on ARF1; the constitutive localization of this
GEF to the plasma membrane may allow it to function in the
absence of PI-3K activity [42]. This differs from the recently
identiﬁed, BFA-resistant GEF cytohesin-4 [43]. Cytohesin-4,
expressed in leukocytes, was capable of activating ARF1 in
vitro but was inactive toward ARF6. Identiﬁcation of the
GEFs responsible for ARF activation during phagocytosis, and
determination of their PI-binding preferences could provide
insight into the differential regulation of ARF GTPases
during phagocytosis.
Materials and Methods
Molecular cloning and DNA manipulation. Plasmids incorporating
monomeric versions (A207K) of the GFP spectral variants ECFP and
Citrine (an EYFP variant) were used for all constructs [44,45]. Human
ARF1 and ARF6 from the UMR cDNA Resource Center (http://www.
cdna.org) were PCR-ampliﬁed for subcloning into pECFP-N1 and
pEYFP-N1 (Clontech, Mountain View, California, United States) on
EcoRI-KpnI fragments producing a fusion to the ﬂuorescent protein
at the C-terminus of the GTPase. To generate YFP-NGAT, the base
pairs encoding amino acid residues 165–210 from transcript variant 1
of human GGA1, a gift from J. Bonifacino, were PCR-ampliﬁed for
insertion into the XhoI-EcoRI site of pEYFP-C1. YFP-NGAT was
mutated to NGAT(A193T, N194Y) in the YFP-NGAT expression
construct using the QuikChange site-directed mutagenesis kit
(Stratagene, La Jolla, California, United States). ARF1(T31N),
ARF1(Q71L), ARF6(T27N), and ARF6(Q67L) were generated from
the appropriate ARF-CFP expression constructs using the Stratagene
QuikChange mutagenesis kit. The sequences of constructs were
conﬁrmed by DNA sequencing at the University of Michigan DNA
Sequencing Core.
Tissue culture and transfection. RAW264.7 macrophage-like cells
were obtained from the American Type Culture Collection (Mana-
ssas, Virginia, United States) and maintained at 37 8C under 5% CO2.
RAW264.7 cells were cultured in Dulbecco’s Modiﬁed Eagle Medium
(DMEM) supplemented with 10% HIFBS, 100 U/ml penicillin, and 100
lg/ml streptomycin, or Advanced-DMEM supplemented with 2%
HIFBS, 4 mM L-glutamine, 20 U/ml penicillin, and 20 lg/ml
streptomycin. Cell culture reagents were products of Invitrogen
(Carlsbad, California, United States). Cells under microscopic
observation were maintained in Leiden chambers (Harvard Appara-
tus, Holliston, Massachusetts, United States) at 37 8C in Ringer’s
buffer (155 mM NaCl, 5mM KCl, 2 mM CaCl2, 1 mM MgCl2,2m M
NaH2PO4, 10 mM glucose, 10 mM HEPES [pH 7.2]). The opsonization
of sheep erythrocytes with rabbit IgG (ICN Biochemicals, Aurora,
Ohio, United States) has been described previously [46].
To prepare RAW264.7 cells for FRET or ratiometric microscopy,
;2.5 3 10
5 cells per coverslip were plated the day before imaging.
Transfection of plasmids encoding ﬂuorescent chimeras was per-
formed ;18 h prior to the start of imaging using FuGene-6 according
to the manufacturer’s recommended protocol (Roche Diagnostics,
Indianapolis, Indiana, United States).
Pharmacological treatments. BFA and LY294002 were purchased
from EMD Biosciences (San Diego, California, United States). Stocks
were prepared by dilution of the lyophilized solids into DMSO to a
concentration of 1 mM for BFA and 10 mM for LY294002. Aliquoted
stocks were stored at 20 8C until needed. BFA was added to the cells
in the Leiden chamber to a ﬁnal concentration of 5 lM, and
ﬂuorescence images were recorded as described below. LY294002 was
added to cells at a ﬁnal concentration of 50 lM 30 min prior to the
addition of opsonized erythrocytes.
FRET microscopy. FRET component ﬂuorescence images were
acquired using a Nikon Eclipse TE-300 inverted microscope with a
603, numerical aperture 1.4, oil-immersion PlanApo objective lens
( N i k o n ,T o k y o ,J a p a n )a n dL a m b d aL Sx e n o na r cl a m pf o r
epiﬂuorescence illumination (Sutter Instruments, Novato, California,
United States). Image acquisition and processing were performed
using Metamorph 6.2r6 (Universal Imaging, Malvern, Pennsylvania,
United States). Fluorescence excitation and emission wavelengths
were selected using a JP4v2 ﬁlter set (Chroma Technology, Rock-
ingham, Vermont, United States) and a Lambda 10–2 ﬁlter wheel
controller (Sutter Instruments) equipped with a shutter for epiﬂuor-
escence illumination control. Phase contrast illumination was
controlled using a Uniblitz VMM-D1 shutter driver (Vincent
Associates, Rochester, New York, United States). Images were
recorded with a Photometrics CoolSnap HQ cooled CCD camera
(Roper Scientiﬁc, Tucson, Arizona, United States). Images were
acquired by positioning excitation and emission ﬁlters to visualize
CFP (ID): excitation at 430 6 12.5 nm, emission at 470 6 15 nm; YFP
(IA): excitation at 500 6 10 nm, emission at 535 6 15 nm; or FRET
(IF): excitation at 430 6 12.5 nm, emission at 535 6 15 nm. Images
were collected with exposure times of 100–400 ms. To account for
variable exposure lengths, image scaling was performed following
shading and bias correction, e.g., to correct for ID:IF:IA exposure
lengths of 200 ms : 200 ms : 100 ms, the shade/bias corrected IA image
was multiplied by two prior to further image processing. Shading
correction images for ID,I A, and IF were collected from a mixture of
CFP and YFP between two coverglasses. Bias-correction images to
correct for camera dark noise were collected with the excitation light
blocked. The FRET parameters a and b were measured from
RAW264.7 cells expressing YFP or CFP, respectively. The parameters
c and n were determined using cells expressing a covalently linked
CFP–YFP molecule, whose FRET efﬁciency (EC) has been measured by
ﬂuorescence lifetime spectroscopy, and back-calculating using the
expression for fA and an updated expression for fD (see Protocol S1),
respectively [24]. The EA,E D, and RM images were calculated from the
corrected ﬂuorescence images and FRET parameters as described
here in Protocol S1 (for ED and RM) and as described in previous work
(EA) [24].
To observe phagocytosis, RAW264.7 cells expressing ﬂuorescent
chimeras were located, and phagocytosis initiated by delivery of ;23
10
5 IgG-opsonized erythrocytes to the chamber. Collection of IA,I D,
IF, and phase contrast images began as erythrocytes landed on cells
expressing ﬂuorescent chimeras. Image sets were recorded within 2 s
at 30-s intervals. Following acquisition of complete time series, shade/
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ARF1 and ARF6 during Phagocytosisbias-corrected IA,I D, and IF images were used to calculate the FRET
stoichiometry images EA,E D,a n dR M. The calculated images
represent: the fraction of YFP chimera (fA) in complex times the
characteristic FRET efﬁciency (EC) of the complex (EA), the fraction
of CFP chimera in complex (fD) times EC (ED), or the molar ratio of
YFP chimera to CFP chimera (RM) at each pixel in the image. Note
that the value of EC for the ARF–CFP–YFP–NGAT interaction is not
required for calculation of EA,E D, and RM.
To measure the BFA-mediated disruption of ARF1 activation at
the Golgi complex, IA,I D,I F, and phase contrast images of RAW264.7
macrophages expressing both ARF1-CFP and YFP-NGAT were
collected before the addition of BFA (ﬁnal concentration of 5 lM).
Following the addition of toxin, ﬂuorescence and phase contrast
images were collected at 30-s intervals. Image processing to obtain
the EA,E D, and RM images was performed as described above. To
deﬁne the Golgi compartment, a manual threshold was applied to the
high intensity region in the shade/bias-corrected ID image. This
threshold was used to create a binary mask; the mask was applied to
the EA,E D, and RM images to deﬁne the region of measurement.
Metamorph’s Integrated Morphometry Analysis was used to measure
the area and average gray value of the resulting region in the masked
EA,E D, and RM images at each time point. As BFA reduced the Golgi
network, the region of high intensity used to make measurements
decreased in size. After ;15–20 min in 50 lM BFA, the measurement
region could no longer be deﬁned due to redistribution of ARF1-
CFP. Cells expressed uniform ED values of ;0 at these time points.
To compare FRET values measured in cells transfected with
different ARF-CFP and YFP-NGAT chimeras, the average ﬂuores-
cence intensities of the masked, shade-corrected, and bias-corrected
IA,I D, and IF component images for each cell were recorded into a
spreadsheet. The average ﬂuorescence values were then used to
calculate EA,E D, and RM using the FRET stoichiometry equations and
EAVG, the arithmetic mean of EA and ED. Because EA and ED are
sensitive to the amount of acceptor and donor available for
incorporation into FRET complexes, these values are dependent on
the value of RM; while EA is suppressed in cells that express a large
excess of YFP relative to CFP, ED is increased in cells with an
overabundance of acceptor. EAVG serves as a weighted average that
adjusts for varying levels of donor and acceptor in a population of
cells, and was therefore used to compare FRET values in cells that
express variable relative amounts of different CFP and YFP chimeras.
The relationships between EA,E D,E AVG, and RM can be seen in Figure
S1. Statistical analysis to compare FRET in cells expressing the wild-
type and mutant chimeras was performed using Prism 3.0 (GraphPad
Software, San Diego, California, United States).
Ratiometric microscopy. During phagocytosis by cells expressing
YFP chimeras, quantiﬁcation of the association of the YFP chimera
with the phagosome is complicated by the changes in optical path
length induced by morphological rearrangements at the cell
periphery near the phagosome. Ratiometric imaging can be used to
distinguish speciﬁc association of a marker with the phagosome from
intensity changes due to the increase in bulk cellular material at the
site of phagocytosis [47,48]. The application of FRET stoichiometry to
ratiometric imaging analysis allows the quantiﬁcation of the molar
ratio of YFP chimera to soluble CFP marker [30]. In the absence of
CFP–YFP energy transfer, the molar ratio can be calculated as:
RM ¼
n
c

aIA
ID
: ð1Þ
The factors a and c are deﬁned as described previously, n is
described in Protocol S1, and we have replaced the notation R with
RM [24]. To make measurements of protein localization that are
independent of the relative transfection efﬁciency of the YFP
chimera and CFP in a particular cell, a recruitment index has been
developed [30]. This recruitment index is calculated as RM for the
phagosome region divided by RM for the entire cell:
Ri ¼
RMP
RMC
¼
½YFPP 
½CFPP 
3
½CFPC 
½YFPC 
¼
½YFPP 
½YFPC 
: ð2Þ
Image collection for ratiometric microscopy was performed as for
FRET microscopy except that only the IA,I D, and phase contrast
images were collected.
Particle-tracking and phagosome analysis. Methods for measuring
phagosome-associated signals using the centroid-tracking algorithm
TRACKOBJ in Metamorph have been described [30,48]. Brieﬂy, the
TRACKOBJ algorithm was used to identify the center of the
erythrocyte in the phase contrast image and to position a 5-lm
circular region encompassing the erythrocyte in the phase contrast,
EA,E D, and RM images. The average EA,E D, and RM values of the
phagosome measurement region, excluding the non-cell portion,
were then recorded for each image in the series. Phagocytic progress
was monitored using the phase-bright to phase-dark transition that
accompanies phagocytosis of opsonized erythrocytes [49]. Phago-
somes were aligned at the time point corresponding to the midpoint
of the phase-bright to phase-dark transition; this corresponds to 7.5
min. For phagocytic cups formed in the presence of LY294002,
particle-tracking measurements were temporally aligned at the onset
of pseudopod extension observed in the ﬂuorescence images.
Measurement of phagocytic efﬁciencies. To quantify the effects of
the ARF GTPase mutants on phagocytosis, phagocytic efﬁciencies
were measured for cells expressing the GTPases as CFP fusions. ;53
10
4 RAW264.7 cells were plated in triplicate onto 13-mm coverslips.
The cells were transfected the same day with CFP-expression plasmid
or plasmids encoding the CFP fusions of ARF1, ARF1(T31N),
ARF1(Q71L), ARF6, ARF6(T27N), or ARF6(Q67L). The following
day, ;10
6 IgG-opsonized sheep erythrocytes were delivered to each
coverslip in 50 lL of warm, serum-free DMEM. Erythrocytes were
allowed to sediment and phagocytosis to proceed for 30 min in a 37
8C–CO2 incubator. Phagocytosis was arrested and unbound eryth-
rocytes removed by rinsing the coverslips three times with PBS
followed by ﬁxation of cells in 20 mM HEPES, 0.2 M sucrose, 4% PFA,
0.01% glutaraldehyde [pH 7.4] for 30 min; ﬁxation and all subsequent
steps were performed at room temperature. Following three rinses
with PBS, cells were treated with sodium borohydride (Sigma Aldrich,
St. Louis, Missouri, United States) to reduce primary ﬂuorescence
induced by glutaraldehyde. Coverslips were incubated with a 1 mg/mL
solution of borohydride in PBS for 5 min. After four incubations in
the borohydride solution, cells were rinsed six times with PBS and
twice with PBS supplemented with 2% goat serum (PBS-GS);
coverslips were left in the second PBS-GS rinse for 15 min to block
nonspeciﬁc binding sites.
To mark uninternalized erythrocytes, coverslips were incubated
with Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen,
Carlsbad, California, United States) at a concentration of 1 lg/mL in
PBS-GS for 30 min. Cells were rinsed with PBS-GS followed by PBS
and mounted on slides using Prolong Gold antifade reagent
(Invitrogen, Carlsbad, California, United States).
Visualization of CFP and Alexa Fluor 488 was accomplished on the
inverted Nikon Eclipse TE300 FRET microscope using the JP4v2 ﬁlter
set. Alexa Fluor 488 was imaged through the YFP channel of this ﬁlter
set. Cells transfected with the CFP expression construct were located
on coverslips, and then the internalized erythrocytes (Alexa488
 ) and
bound, uninternalized erythrocytes (Alexa488
þ) counted. The percent
phagocytosis was calculated from at least 25 CFP-positive macro-
phages on each coverslip as:
%Phagocytosis ¼
AlexaFluor488 erythrocytes
AlexaFluor488 erythrocytes þ AlexaFluor488þerythrocytes
3100:
ð3Þ
The binding index was calculated as the sum of the uninternalized
and internalized erythrocytes per macrophage. Statistical analysis of
the phagocytic efﬁciencies was performed using SigmaPlot 8.0 (Systat
Software, Point Richmond, California, United States).
Supporting Information
Figure S1. FRET Values (EA,E D, and EAVG) Measured from Cells
Expressing ARF1-CFP and YFP-NGAT and YFP-Rac2V12 and PBD-
CFP, Graphed as Functions of RM
The average FRET values were calculated from ;40 cells expressing
ARF1-CFP and YFP-NGAT (A) or ;125 cells expressing YFP-Rac2V12
and PBD-CFP (B). The construction of the Rac-PBD FRET pair is
described elsewhere [30]. The values of EA,E D, and EAVG for each cell
were then plotted against the corresponding measured RM values. For
RM values below 1, the CFP donor is in excess, while for RM values
above 1, the YFP acceptor is the excess binding partner. For low RM
values, more acceptors are able to form complex with the excess
donors, leading to relatively higher EA values; however, the lack of
sufﬁcient acceptors reduces the fraction of donors that can enter into
FRET complexes and reduces ED. In the case of excess acceptors, the
impact on EA and ED values is reversed, with EA being suppressed.
EAVG, though, does not demonstrate this sharp, asymmetric depend-
ence on RM. When graphed as a function of RM,E AVG is essentially
independent of RM, particularly in the range RM ¼ 0.1 – 10. Because
EA and ED are distinctly dependent on RM,E AVG is preferred for
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values differ between some samples.
Found at DOI: 10.1371/journal.pbio.0040162.sg001 (204 KB PDF).
Protocol S1. Explanation of the Changes to the ED and RM
Expressions
Found at DOI: 10.1371/journal.pbio.0040162.sd001 (25 KB DOC).
Table S1. Table of EA,E D,E AVG, and RM Values from Cells Expressing
the ARF-CFP and YFP-NGAT Molecules Measured for Figure 1C
Found at DOI: 10.1371/journal.pbio.0040162.st001 (40 KB DOC).
Video S1. Movie of ARF6 Activation during Phagocytosis
A phase contrast movie of an RAW264.7 macrophage engulﬁng an
IgG-coated RBC is shown in the panel to the left. IA,I D, and IF images
were used to calculate the time-lapse RM images (center panel), ED
images (right-hand panel) and EA images (unpublished data).
Activated ARF6 can be seen at a site of rufﬂing (upper left of the
macrophage, near the center of the panels). Phagocytosis of an
erythrocyte, initiated below the rufﬂe, induced the activation of ARF6
at the leading edge of the phagosome pseudopod during the
extension phase. ARF6 was deactivated as the phagosome sealed.
All videos seen here play at 6 frames/s. Frames were collected at 30-s
intervals.
Found at DOI: 10.1371/journal.pbio.0040162.sv001 (2.9 MB MOV).
Video S2. Movie of ARF1 Activation during Phagocytosis
Images shown left to right: phase contrast, RM and ED time-lapse
images of a macrophage expressing ARF1-CFP and YFP-NGAT. The
activation of ARF1-CFP at the phagosome is revealed in the ED image.
ARF1 activation at the phagosome increased during the extension
phase and was resolved during closure. The juxtanuclear Golgi
compartment is visible in the ED image as well, to the lower right of
the forming phagosome. Levels of activated ARF1 at the Golgi did not
vary during phagocytosis.
Found at DOI: 10.1371/journal.pbio.0040162.sv002 (2.2 MB MOV).
Video S3. Movie of ARF1 Activation during Phagocytosis by a BFA-
Treated Macrophage
Panels in the video, left to right: phase contrast, RM and ED images
from a macrophage expressing ARF1-CFP and YFP-NGAT, and
treated with 5 lM BFA for 30 min prior to microscopic observation.
Exposure to BFA prevented the activation of ARF1 at the Golgi—no
regions of high FRET are visible near the nucleus in the ED image at
the start of the movie. However, the two phagocytic events (lower
right, followed by upper left) led to the activation of ARF1, indicating
that ARF1 activation at the phagosome is mediated by a BFA-resistant
ARNO/cytohesin-family GEF.
Found at DOI: 10.1371/journal.pbio.0040162.sv003 (2.7 MB MOV).
Video S4. Movie of ARF6 Activation in the Presence of LY294002
RAW264.7 macrophages co-transfected with ARF6-CFP and YFP-
NGAT were incubated in 50 lM LY294002 for 30 min before the
addition of IgG-opsonized erythrocytes. The presented images, left to
right, are: phase contrast, RM and ED time-lapse images. Following
binding of a particle at the right, ARF6-CFP was activated and
pseudopod extension commenced. GTP-bound ARF6-CFP continued
to accumulate in the phagocytic cup and was not deactivated during
observation. The accumulation of ARF6-CFP at the arrested
phagocytic cup can be seen in the RM image series (the blue band
at the phagocytic cup represents a molar excess of ARF6-CFP relative
to YFP-NGAT). The generation of ARF6-GTP in the absence of PI-3K
function indicates ARF6 is activated at the phagosome by a PI-3K-
independent GEF activity.
Found at DOI: 10.1371/journal.pbio.0040162.sv004 (2.8 MB MOV).
Video S5. Movie of ARF1 Activity with PI-3K Activity Blocked by
LY294002
RAW264.7 macrophages co-transfected with ARF1-CFP and YFP-
NGAT demonstrated high FRET signals in the area of their Golgi
network in the presence of LY294002: the nucleus is visible in the
phase contrast image shown at the left; next to the nucleus, the
crescent-shaped region of high ED (far-right panel) corresponds to
the Golgi apparatus. The Golgi is also visible in the RM image (center
panel) where ARF1-CFP is present in excess over YFP-NGAT. Cells
treated with LY294002 could bind opsonized particles and form
phagocytic cups but could not complete phagocytosis. At the upper
left and right of the macrophage, binding of opsonized erythrocytes
was not accompanied by the activation of ARF1-CFP. This result
indicates that ampliﬁcation of FccR-signaling by PI-3K is required for
the activation of ARF1 at the phagosome.
Found at DOI: 10.1371/journal.pbio.0040162.sv005 (2.9 MB MOV).
Accession Numbers
Genbank (http://www.ncbi.nlm.nih.gov/Genbank) accession numbers
are: ARF1 cDNA used to produce ARF1-CFP (AF493881), ARF6
source cDNA (AF493885), GGA1 transcript variant used to create
NGAT (NM_013365). All plasmids used to produce the data for this
manuscript can be obtained from the Addgene plasmid repository
(http://www.addgene.org/Joel_Swanson), and the Addgene plasmid ID
numbers are 11381–11390.
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